Jay Steven Loeffler, M.D.
Co-Author
This page shows the publications co-authored by Jay Loeffler and Peter Black.
Connection Strength
2.072
-
Aggressive surgery and focal radiation in the management of meningiomas of the skull base: preservation of function with maintenance of local control. Acta Neurochir (Wien). 2001; 143(6):555-62.
Score: 0.228
-
Stereotactic techniques in managing pediatric brain tumors. Childs Nerv Syst. 1993 Sep; 9(6):343-6; discussion 347.
Score: 0.137
-
Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol. 1992 Sep; 10(9):1379-85.
Score: 0.128
-
Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6):1455-62.
Score: 0.113
-
Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms. Clin Cancer Res. 2006 Aug 01; 12(15):4738-46.
Score: 0.084
-
Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity. Neurosurgery. 2005 Jul; 57(1):60-70; discussion 60-70.
Score: 0.078
-
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol. 2004 May 15; 22(10):1926-33.
Score: 0.072
-
Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol. 2002 Feb 15; 20(4):1063-8.
Score: 0.062
-
Linac radiosurgery for skull base meningiomas. Acta Neurochir (Wien). 2001 Nov; 143(11):1141-52.
Score: 0.060
-
Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery. 2000 Sep; 47(3):623-31; discussion 631-2.
Score: 0.056
-
Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg. 1999 Jan; 90(1):72-7.
Score: 0.050
-
Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys. 1998 Oct 01; 42(3):573-80.
Score: 0.049
-
Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery. 1998 Mar; 42(3):446-53; discussion 453-4.
Score: 0.047
-
Permanent low-activity iodine-125 implants for cerebral metastases. J Neurooncol. 1997 Jul; 33(3):213-21.
Score: 0.045
-
A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas. Clin Cancer Res. 1997 Mar; 3(3):381-7.
Score: 0.044
-
Gangliogliomas in adults. Cancer. 1997 Jan 01; 79(1):127-31.
Score: 0.043
-
The influence of Harvey Cushing on neuroradiologic therapy. Radiology. 1996 Dec; 201(3):671-4.
Score: 0.043
-
Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas: preliminary results. Int J Radiat Oncol Biol Phys. 1996 Aug 01; 36(1):141-5.
Score: 0.042
-
Historical vignette: The radium bomb: Harvey Cushing and the interstitial irradiation of gliomas. J Neurosurg. 1996 Mar; 84(3):530-2.
Score: 0.041
-
High-grade astrocytomas. Neurol Clin. 1995 Nov; 13(4):875-900.
Score: 0.040
-
Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery. 1995 Feb; 36(2):275-82; discussion 282-4.
Score: 0.038
-
Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst. 1995 Jan 04; 87(1):34-40.
Score: 0.038
-
Results of radiosurgery in the management of recurrent and residual medulloblastoma. Pediatr Neurosurg. 1995; 22(4):197-203.
Score: 0.038
-
Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer. 1994 Jun 15; 73(12):3029-36.
Score: 0.036
-
Autocrine regulation of the production of the gaseous messenger nitric oxide in a glioblastoma cell line. Exp Cell Res. 1994 Jan; 210(1):137-9.
Score: 0.035
-
Stereotactic radiotherapy: a technique for dose optimization and escalation for intracranial tumors. Acta Neurochir Suppl. 1994; 62:118-23.
Score: 0.035
-
Selected human leukocyte antigen class II polymorphisms and risk of adult glioma. J Neuroimmunol. 2011 Apr; 233(1-2):185-91.
Score: 0.029
-
DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol. 2010 Jan; 12(1):37-48.
Score: 0.027
-
Occupational exposure to magnetic fields and the risk of brain tumors. Neuro Oncol. 2009 Jun; 11(3):242-9.
Score: 0.025
-
Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol. 2008 Oct; 10(5):709-15.
Score: 0.024
-
Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol. 2008 Aug; 10(4):553-9.
Score: 0.024
-
A STAT3 Gene Expression Signature in Gliomas is Associated with a Poor Prognosis. Transl Oncogenomics. 2007; 2:99-105.
Score: 0.023
-
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1655-61.
Score: 0.023
-
Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2514-20.
Score: 0.021
-
Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults. Am J Epidemiol. 2007 Jan 01; 165(1):63-71.
Score: 0.021
-
Sociodemographic indicators and risk of brain tumours. Int J Epidemiol. 2003 Apr; 32(2):225-33.
Score: 0.017
-
Laterality of brain tumors. Neuroepidemiology. 2003 Mar-Apr; 22(2):130-8.
Score: 0.017
-
Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res. 2001 Aug; 7(8):2387-95.
Score: 0.015
-
Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys. 2001 Jul 15; 50(4):929-35.
Score: 0.015
-
Cellular-telephone use and brain tumors. N Engl J Med. 2001 Jan 11; 344(2):79-86.
Score: 0.014
-
Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones. J Neuropathol Exp Neurol. 2000 Dec; 59(12):1044-50.
Score: 0.014
-
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol. 2000 Feb; 18(4):708-15.
Score: 0.013
-
Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg. 1998 Jul; 89(1):60-8.
Score: 0.012
-
Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma. Int J Radiat Oncol Biol Phys. 1998 Jan 01; 40(1):65-70.
Score: 0.012
-
Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer. 1996 Aug 15; 78(4):864-73.
Score: 0.011
-
Anesthesia for stereotactic radiosurgery in children. J Neurosurg Anesthesiol. 1995 Apr; 7(2):100-8.
Score: 0.010
-
A phase I study of etanidazole and radiotherapy in malignant glioma. Int J Radiat Oncol Biol Phys. 1994 Jun 15; 29(3):617-20.
Score: 0.009
-
Complications of therapy for venous thromboembolic disease in patients with brain tumors. Neurology. 1993 Jun; 43(6):1111-4.
Score: 0.008
-
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993 Apr 15; 71(8):2585-97.
Score: 0.008
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.